SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-018665
Filing Date
2023-11-13
Accepted
2023-11-13 06:09:40
Documents
56
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mist-20230930x10q.htm   iXBRL 10-Q 1492722
2 EX-10.1 mist-20230930xex10d1.htm EX-10.1 49786
3 EX-10.2 mist-20230930xex10d2.htm EX-10.2 25061
4 EX-31.1 mist-20230930xex31d1.htm EX-31.1 12318
5 EX-31.2 mist-20230930xex31d2.htm EX-31.2 12469
6 EX-32.1 mist-20230930xex32d1.htm EX-32.1 9443
  Complete submission text file 0001558370-23-018665.txt   6019407

Data Files

Seq Description Document Type Size
7 EX-101.SCH mist-20230930.xsd EX-101.SCH 35280
8 EX-101.CAL mist-20230930_cal.xml EX-101.CAL 32423
9 EX-101.DEF mist-20230930_def.xml EX-101.DEF 136737
10 EX-101.LAB mist-20230930_lab.xml EX-101.LAB 319281
11 EX-101.PRE mist-20230930_pre.xml EX-101.PRE 242102
50 EXTRACTED XBRL INSTANCE DOCUMENT mist-20230930x10q_htm.xml XML 1168884
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38899 | Film No.: 231394714
SIC: 2834 Pharmaceutical Preparations